Company
Myeloid
United StatesBiotechnologyHealth CareMedicalTherapeuticsDescription
Myeloid Therapeutics, Inc. , a clinical stage oncology company, has appointed Matthew Maurer, M.D. as Chief Medical Officer.
Quick answer
Myeloid Announces Appointment of Matthew Maurer, M.D. as Chief Medical Officer (December 6, 2023). Myeloid is based in United States.
- What did Myeloid announce on December 6, 2023?
- Myeloid Therapeutics, Inc. , a clinical stage oncology company, has appointed Matthew Maurer, M.D. as Chief Medical Officer.
- What does Myeloid do?
- Myeloid Therapeutics, Inc. is a clinical stage oncology company developing novel therapies for cancer.
- Where is Myeloid based?
- Myeloid is based in United States.
- Which similar companies made leadership changes around the same time?
- TScan Therapeutics, Inc. (December 4, 2023), Smart Immune (December 4, 2023), NYU Langone Health (December 1, 2023) and Diakonos Oncology (November 20, 2023) also announced leadership changes within 45 days of Myeloid.
Source: Fundz verified event record.
Other recent leadership changes in Medical and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- TScan Therapeutics Expands Manufacturing Leadership with the Appointment of Justin McCue, Ph.D., as Chief Technology Officer (December 4, 2023)
- Smart Immune appoints Dr. Rahim Fandi, M.D, PhD as Chief Medical Officer, strengthening C suite with seasoned oncology expertise (December 4, 2023)
- NYU Langone Hospital--Long Island Appoints Mario E. Lacouture, MD, as the New Chief of Dermatology (December 1, 2023)
- Diakonos Oncology Names Ian H. Bellayr, Ph.D. Chief Regulatory Officer (November 20, 2023)
- Aethlon Medical Announces Appointment of James B. Frakes, M.B.A. as Interim Chief Executive Officer and Guy Cipriani, M.B.A. as Chief Operating Officer (November 13, 2023)
- Incendia Therapeutics Appoints Wendye Robbins, M.D., as Chief Executive Officer and Doses First Patient in Phase 1b Clinical Trial of PRTH-101, a Novel DDR1 Inhibitor (November 13, 2023)
Who to call at Myeloid, and when
A new leader at Myeloid brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Myeloid raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Myeloid, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Myeloid. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Myeloid changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Myeloid changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.